Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells

Cell Cycle

Volumn 12, Issue 4, 2013, Pages 596-605

  Caldon, C Elizabeth ^a   Sergio, C Marcelo ^a   Sutherland, Robert L ^a,b   Musgrove, Elizabeth A ^a,b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cell cycle; Cyclin E1; Cyclin E2; Fbw7; Proliferation

Indexed keywords

CYCLIN E; CYCLIN E1; CYCLIN E2; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL CYCLE S PHASE; CELL PROLIFERATION; DNA REPLICATION; DOWN REGULATION; FLOW CYTOMETRY; GENETIC ASSOCIATION; GENOMIC INSTABILITY; IMMUNOBLOTTING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; UBIQUITINATION;

EID: 84874585560     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.23409     Document Type: Article

References (48)

1. Hwang HC, Clurman BE. Cyclin E in normal and neoplastic cell cycles. Oncogene 2005; 24:2776-86; PMID:15838514; http://dx.doi.org/10.1038/sj.onc. 1208613
2. Welcker M, Singer J, Loeb KR, Grim J, Bloecher A, Gurien-West M, et al. Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol Cell 2003; 12:381-92; PMID:14536078; http://dx.doi.org/10.1016/S1097-2765(03) 00287-9
3. Fbw7 ubiquitin ligase. Science 2001; 294:173-7; PMID:11533444; http://dx.doi.org/10. 1126/science.1065203
4. Juan G, Cordon-Cardo C. Intranuclear compartmentalization of cyclin E during the cell cycle: disruption of the nucleoplasm-nucleolar shuttling of cyclin E in bladder cancer. Cancer Res 2001; 61:1220-6; PMID:11221854
5. Ekholm-Reed S, Méndez J, Tedesco D, Zetterberg A, Stillman B, Reed SI. Deregulation of cyclin E in human cells interferes with prereplication complex assembly. J Cell Biol 2004; 165:789-800; PMID:15197178; http://dx.doi.org/10.1083/jcb.200404092
6. (Kip1), polyploidy and centrosome overduplication. EMBO J 2000; 19:2069-81; PMID:10790373; http://dx.doi.org/10.1093/emboj/19.9.2069
7. (Cdh1). J Cell Biol 2007; 178:371-85; PMID:17664332; http://dx.doi.org/10.1083/jcb.200703202
8. Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 2008; 8:83-93; PMID:18094723; http://dx.doi.org/10.1038/nrc2290
9. Ekholm-Reed S, Spruck CH, Sangfelt O, van Drogen F, Mueller-Holzner E, Widschwendter M, et al. Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer. Cancer Res 2004; 64:795-800; PMID:14871801; http://dx.doi.org/10.1158/0008-5472.CAN-03-3417
10. Minella AC, Loeb KR, Knecht A, Welcker M, Varnum-Finney BJ, Bernstein ID, et al. Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo. Genes Dev 2008; 22:1677-89; PMID:18559482; http://dx.doi.org/10.1101/gad.1650208
11. Geng Y, Yu Q, Sicinska E, Das M, Schneider JE, Bhattacharya S, et al. Cyclin E ablation in the mouse. Cell 2003; 114:431-43; PMID:12941272; http://dx.doi.org/10.1016/S0092-8674(03)00645-7
12. Gudas JM, Payton M, Thukral S, Chen E, Bass M, Robinson MO, et al. Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers. Mol Cell Biol 1999; 19:612-22; PMID:9858585
13. Lauper N, Beck AR, Cariou S, Richman L, Hofmann K, Reith W, et al. Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle. Oncogene 1998; 17:2637-43; PMID:9840927; http://dx.doi.org/10.1038/sj. onc.1202477
14. 1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins. Oncogene 1998; 17:2787-98; PMID:9840943; http://dx.doi. org/10.1038/sj.onc. 1202505
15. Caldon CE, Musgrove EA. Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer. Cell Div 2010; 5:2; PMID:20180967; http://dx.doi.org/10.1186/1747-1028-5-2
16. Frietze S, Lupien M, Silver PA, Brown M. CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1. Cancer Res 2008; 68:301-6; PMID:18172323; http://dx.doi.org/10.1158/0008-5472.CAN-07- 1983
17. Fabbrizio E, El Messaoudi S, Polanowska J, Paul C, Cook JR, Lee JH, et al. Negative regulation of transcription by the type II arginine methyltransferase PRMT5. EMBO Rep 2002; 3:641-5; PMID:12101096; http://dx.doi.org/10.1093/embo-reports/kvf136
18. Pal S, Vishwanath SN, Erdjument-Bromage H, Tempst P, Sif S. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol Cell Biol 2004; 24:9630-45; PMID:15485929; http://dx.doi.org/10.1128/MCB.24.21.9630-9645.2004
19. (Fbxw7/hCdc4) targets cyclin E2 for ubiquitindependent proteolysis. Exp Cell Res 2009; 315:1832-9; PMID:19084516; http://dx.doi.org/10.1016/j. yexcr.2008.11.017
20. Caldon CE, Sergio CM, Kang J, Muthukaruppan A, Boersma MN, Stone A, et al. Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells. Mol Cancer Ther 2012; 11:1488-99; PMID:22564725; http://dx.doi.org/10.1158/1535-7163.MCT-11-0963
21. Gu Z, Inomata K, Ishizawa K, Horii A. The FBXW7 β-form is suppressed in human glioma cells. Biochem Biophys Res Commun 2007; 354:992-8; PMID:17274947; http://dx.doi.org/10.1016/j. bbrc.2007.01.080
22. Hao B, Oehlmann S, Sowa ME, Harper JW, Pavletich NP. Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases. Mol Cell 2007; 26:131-43; PMID:17434132; http://dx.doi.org/10.1016/j.molcel. 2007.02.022
23. Grim JE, Gustafson MP, Hirata RK, Hagar AC, Swanger J, Welcker M, et al. Isoform-and cell cycledependent substrate degradation by the Fbw7 ubiquitin ligase. J Cell Biol 2008; 181:913-20; PMID:18559665; http://dx.doi.org/10.1083/ jcb.200802076
24. Minella AC, Welcker M, Clurman BE. Ras activity regulates cyclin E degradation by the Fbw7 pathway. Proc Natl Acad Sci U S A 2005; 102:9649-54; PMID:15980150; http://dx.doi.org/10.1073/pnas.0503677102
25. Fbw7 cooperatively restrain cyclin E-associated genome instability. Oncogene 2007; 26:6948-53; PMID:17486057; http://dx.doi.org/10.1038/sj.onc.1210518
26. van Drogen F, Sangfelt O, Malyukova A, Matskova L, Yeh E, Means AR, et al. Ubiquitylation of cyclin E requires the sequential function of SCF complexes containing distinct hCdc4 isoforms. Mol Cell 2006; 23:37-48; PMID:16818231; http://dx.doi.org/10.1016/j. molcel.2006.05.020
27. Wang H, Zhang X, Geng L, Teng L, Legerski RJ. Artemis regulates cell cycle recovery from the S phase checkpoint by promoting degradation of cyclin E. J Biol Chem 2009; 284:18236-43; PMID:19423708; http://dx.doi.org/10.1074/jbc. M109.002584
28. Theodorou V, Kimm MA, Boer M, Wessels L, Theelen W, Jonkers J, et al. MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer. Nat Genet 2007; 39:759-69; PMID:17468756; http://dx.doi.org/10.1038/ng2034
29. Sieuwerts AM, Look MP, Meijer-van Gelder ME, Timmermans M, Trapman AM, Garcia RR, et al. Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients. Clin Cancer Res 2006; 12:3319-28; PMID:16740753; http://dx.doi.org/10.1158/1078-0432.CCR-06-0225
30. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 2006; 98:262-72; PMID:16478745; http://dx.doi.org/10.1093/jnci/djj052
31. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415:530-6; PMID:11823860; http://dx.doi. org/10.1038/415530a
32. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005; 365:671-9; PMID:15721472
33. Wang L, Shao ZM. Cyclin e expression and prognosis in breast cancer patients: a meta-analysis of published studies. Cancer Invest 2006; 24:581-7; PMID:16982462; http://dx.doi.org/10.1080/07357900600894799
34. Liang Y, Gao H, Lin SY, Goss JA, Brunicardi FC, Li K. siRNA-based targeting of cyclin E overexpression inhibits breast cancer cell growth and suppresses tumor development in breast cancer mouse model. PLoS One 2010; 5:e12860; PMID:20877462; http://dx.doi. org/10.1371/journal.pone.0012860
35. Lapenna S, Giordano A. Cell cycle kinases as therapeutic targets for cancer. Nat Rev Drug Discov 2009; 8:547-66; PMID:19568282; http://dx.doi. org/10.1038/nrd2907
36. Galimberti F, Thompson SL, Liu X, Li H, Memoli V, Green SR, et al. Targeting the cyclin E-Cdk-2 complex represses lung cancer growth by triggering anaphase catastrophe. Clin Cancer Res 2010; 16:109-20; PMID:20028770; http://dx.doi.org/10.1158/1078-0432.CCR-09-2151
37. Caldon CE, Lee CSL, Sutherland RL, Musgrove EA. Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiation. Oncogene 2008; 27:126-38; PMID:17599043; http://dx.doi. org/10.1038/sj.onc.1210622
38. (Kip1) association with cyclin E-Cdk2. J Biol Chem 2001; 276:47675-83; PMID:11590147; http://dx.doi. org/10.1074/jbc.M106371200
39. Caldon CE, Swarbrick A, Lee CS, Sutherland RL, Musgrove EA. The helix-loop-helix protein Id1 requires cyclin D1 to promote the proliferation of mammary epithelial cell acini. Cancer Res 2008; 68:3026-36; PMID:18413773; http://dx.doi.org/10.1158/0008-5472.CAN-07-3079
40. 1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J Biol Chem 1997; 272:10882-94; PMID:9099745; http://dx.doi.org/10.1074/jbc.272.16.10882
41. Prall OWJ, Rogan EM, Musgrove EA, Watts CKW, Sutherland RL. c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry. Mol Cell Biol 1998; 18:4499-508; PMID:9671459
42. Caldon CE, Sergio CM, Schütte J, Boersma MN, Sutherland RL, Carroll JS, et al. Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc. Mol Cell Biol 2009; 29:4623-39; PMID:19564413; http://dx.doi.org/10.1128/MCB. 00269-09
43. Juan G, Darzynkiewicz Z. Bivariate analysis of DNA content and expression of cyclin proteins. Current protocols in cytometry. Hoboken, NJ, USA: John Wiley & Sons, 2007
44. Flow Jo. Ashland, OR, USA: Tree Star Inc., 2008
45. Flow Cytometry. Principles and Applications. Totowa, New Jersey: Humana Press, 2007
46. Ormerod MG. Flow Cytometry-A Basic Introduction. Los Angeles, CA: De Novo Software, 2008
47. Hansen RS, Thomas S, Sandstrom R, Canfield TK, Thurman RE, Weaver M, et al. Sequencing newly replicated DNA reveals widespread plasticity in human replication timing. Proc Natl Acad Sci U S A 2010; 107:139-44; PMID:19966280; http://dx.doi. org/10.1073/pnas.0912402107
48. Lam N, Sandberg ML, Sugden B. High physiological levels of LMP1 result in phosphorylation of eIF2 α in Epstein-Barr virus-infected cells. J Virol 2004; 78:1657-64; PMID:14747531; http://dx.doi. org/10.1128/JVI.78.4.1657-1664. 2004